Healthcare

Nyrada (ASX:NYR) Advances Clinical Trials with NYR-BI03 Amid ASX 200 Biopharma Developments

May 02, 2025 12:30 PM AEST| By Team Kalkine Media

Highlights:,Nyrada (ASX:NYR) progresses to a new phase in its clinical evaluation of NYR-BI03,NYR-BI03 demonstrates effectiveness in neuroprotection and cardiac research models,Collaborative studies expand the therapeutic profile of NYR-BI03 in brain...

Investors who put their money into Genetic Signatures (ASX:GSS) three years ago are still facing a 51% loss, despite seeing a 16% increase over the past week.

February 27, 2025 01:31 PM AEDT| By Team Kalkine Media

Highlights:,The stock price of Genetic Signatures Limited has experienced an upward movement this week.,Over the past several years, revenue has shown a downward trend, impacting overall stock performance.,Recent share acquisitions by company insider...

Patrys First Half 2025 Earnings Report: Loss of AU$0.001 per share, consistent with the AU$0.001 loss in the first half of 2024.

February 26, 2025 01:32 PM AEDT| By Team Kalkine Media

Highlights:,Revenue experienced an increase compared to the same period last year,Net loss showed a notable decline, reflecting improved financial performance,Shares experienced an upward trend over the past week,Patrys Limited (ASX:PAB),, operating...

Visionflex Group First Half 2025 Earnings: Loss of AU$0.001 per share (compared to a loss of AU$0.001 in the first half of 2024)

February 24, 2025 07:38 PM AEDT| By Team Kalkine Media

Highlights:,Visionflex Group’s revenue saw a notable decrease from the previous year.,Net loss expanded significantly compared to the same period last year.,Share price remained stable despite financial challenges.,Visionflex Group (ASX:VFX),operates...